The effect of vanadium-contaminated commercially available albumin solutions on renal tubular function

Clinical Nephrology

Volumn 53, Issue 6, 2000, Pages 473-478

  Heinemann, G ^a   Braun, S ^b   Overbeck, M ^b   Page, M ^b   Michel, J ^b   Vogt, W ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

glutathione S transferase; Biological half life; Parenteral infusion therapy; Proximal tubular damage; Renal function; Vanadium

Indexed keywords

ALBUMIN; GLUTATHIONE TRANSFERASE; N ACETYL BETA GLUCOSAMINIDASE; VANADIUM;

ADULT; ARTICLE; CASE REPORT; CONTAMINATION; EXTRACORPOREAL CIRCULATION; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HUMAN; KIDNEY INJURY; KIDNEY TUBULE FUNCTION; MALE; REFERENCE VALUE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESUSCITATION; URINARY EXCRETION;

ALBUMINS; CATHETERIZATION, CENTRAL VENOUS; DRUG CONTAMINATION; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY TUBULES; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; POSTOPERATIVE CARE; VANADIUM;

EID: 0034084096     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Boden G, Chen X, Ruiz J, van-Rossum GD, Turco S 1996 Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Metabolism 45: 1130-1135
2. Boscolo P, Carmignani M, Volpe AR, Felaco M, del Rosso G, Porcelli G, Giuliano G 1994 Renal toxicity and arterial hypertension in rats chronically exposed to vanadate. Occup Environ Med 51: 500-503
3. Cochrane Injuries Group Albumin reviewers 1998 Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 317: 235-240
4. Cohen N, Halberstam M, Shlimovich P, Chang CJ, Shamoon H, Rossetti L 1995 Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 95: 2501-2509
5. Cornelis R, Versieck J, Mees L, Hoste J, Barbier F 1981 The ultratrace element vanadium in human serum. Biol Trace Elem Res 3: 257-263
6. Dafnis E, Sabatini S 1994 Biochemistry and pathophysiology of vanadium. Nephron 67: 133-143
7. Dafnis E, Spohn M, Lonis B, Kurtzman NA, Sabatini S 1992 Vanadate causes hypokalemic distal renal tubular acidosis. Am J Physiol 262: F449-F453
8. Dehne MG, Boldt J, Heise D, Sablotzki A, Hempelmann G 1995 Tamm-Horsfall-Protein, alphal-und beta2-Mikroglobulin als Nierenfunktionsmarker in der Herzchirurgie. Anaesthesist 44: 545-551
9. Gammelgaard B, Sandberg E 1989 Potential toxicity from nickel contamination of intravenous fluids. J Trace Elem Electrolytes Health Dis 3: 39-42
10. Goldfine AB, Simonson DC, Folli F, Patti ME, Kahn CR 1995 Metabolic effects of sodium metavanadate in humans with insulin-dependent diabetes mellitus in vivo and in vitro studies. J Clin Endocrinol Metab 80: 3311-3320
11. Gramm HJ, Baudisch H, Schlagenhaufer S, Goecke J, Frucht U 1987 Spurenelementgehalt in Lösungen zur parenteralen Ernährung und Blutderivaten. Infusions-therapie 14: 290-294
12. Grantham JJ 1980 The renal sodium pump and vanadate. Am J Physiol 239: F97-F106
13. Grantham JJ, Glynn IM 1979 Renal Na,K-ATPase: determinants of inhibition by vanadium. Am J Physiol 236: F530-F535
14. Heinemann G, Vogt W 1996 Quantification of vanadium in serum by electrothermal atomic absorption spectrometry. Clin Chem 42: 1275-1282
15. Higashi Y, Bello-Reuss E 1980 Effects of sodium orthovanadate on whole kidney and single nephron function. Kidney Int 18: 302-308
16. Nechay BR 1984 Mechanisms of action of vanadium. Ann Rev Pharmacol Toxicol 24: 501-524
17. Nielsen FH, Uthus EO 1990 The essentiality and metabolism of vanadium. In: Chasteen ND (ed) Vanadium in Biological Systems. Kluwer Academic Publishers, Dordrecht, pp 51-62
18. Phillips TD, Nechay BR, Heidelbaugh ND 1983 Vanadium: chemistry and the kidney. Fed Proc 42: 2969-2973
19. Quinlan GJ, Coudray C, Hubbard A, Gutteridge JMC 1992 Vanadium and copper in clinical solutions of albumin and their potential to damage protein structure. J Pharm Sci 81: 611-614
20. Ramasarma T, Crane FL 1981 Does vanadium play a role in cellular regulation? Curr Top Cell Regul 20: 247-301
21. +-ATPase). Semin Nephrol 11: 37-44
22. Sakurai H, Nishida IV, Koyama M, Takada J 1987 Occurrence of vanadium ion in serum albumins. Biochem Biophys Acta 924: 562-563
23. Schaller KH 1994 Vanadium. In: Herber RFM, Stoeppler M (ed) Techniques and Instrumentation in Analytical Chemistry. Elsevier, Amsterdam, pp 527-539
24. Seeling W, Dölp R, Ahnefeld FW, Dick W 1975 Untersuchungen zum Verhalten des Chroms in Serum und Urin polytraumatisierter Patienten sowie der Chromkonzentration verschiedener Infusionslösungen. Infusionstherapie 2: 144-150
25. Sundberg AG, Appelkvist EL, Backman L, Dallner G 1994 Urinary pi-class glutathione transferase as an indicator of tubular damage in the human kidney. Nephron 67: 308-316
26. Sunderman FW 1983 Potential toxicity from nickel contamination of intravenous fluids. Ann Clin Lab Sci 13: 1-4
27. Vyskocil A, Senft V, Viau C, Cizkova M, Kohout J 1994 Biochemical renal changes in workers exposed to soluble nickel compounds. Hum Exp Toxicol 13: 257-261
28. Wedeen RP, Qian LF 1991 Chromium-induced kidney disease. Environ Health Perspect 92: 71-74
29. Westenfelder Ch, Hamburger RK, Garcia ME 1981 Effect of vanadate on renal tubular function in rats. Am J Physiol 240: F522-F529
30. Willsky GR 1990 Vanadium in the biosphere. In: Chasteen ND (ed) Vanadium in Biological Systems. Kluwer Academic Publishers, Dordrecht, pp 1-24
31. Yasuma F, Yasuura K, Okamoto H, Miyazaki M, Hirose S, Akune J, Kondo T, Ogawa Y, Seki A 1984 Tubular dysfunction after open heart surgery. Nippon Geka Gakkai Zasshi 85: 415-420
32. Yu H, Yanagisawa Y, Forbes MA, Cooper EH, Crockson RA, MacLennan IC 1983 Alpha-1-microglobulin: an indicator protein for renal tubular function. J Clin Pathol 36: 253-259